Revised SPC: Busilvex (busulfan) 6 mg/ml concentrate for solution for infusion

SPC updated to note increases in busulfan exposure have been observed when administered concomitantly with deferasirox. In those who are or have recently been treated with deferasirox, busulfan plasma concentrations should be monitored regularly, and dose adjusted if necessary.

Source:

electronic Medicines compendium